Abstract：OBJECTIVE: To investigate the expression of serine protease Omi/HtrA2 in kidneys of postasphyxial neonatal rats, and to study the effects of Ucf-101 on apoptosis and the expression of Omi/HtrA2 in these rats. METHODS: Seventy-two neonatal Wistar rats of 7-10 days old were randomly divided into 3 groups: control, postasphyxial model, Ucf-101-treated postasphyxial．The postasphyxial model was established by normobaric asphyxia．Expression of Omi/HtrA2 was determined with streptavidin-peroxidase immunohistochemistry 2, 24 and 48 hrs after asphyxia. Terminal deoxynuleotidyl-mediated nick end labeling (TUNEL) was used to ascertain the apoptosis of renal cells. RESULTS: Compared with the control group, Omi／HtrA2 expression in renal cells began to increase 2 hrs after asphyxia and peaked at 24 hrs. The expression of Omi/HtrA2 in the Ucf-101-treated postasphyxial group was significantly lower than that in the postasphyxial model group (P<0.01). TUNEL-positive cells began to increase 2 hrs after asphyxia and peaked at 24 hrs in the postasphyxial model group when compared with the control group. The number of TUNEL-positive cells in the Ucf-101-treated postasphyxial group was significantly lower than that in the postasphyxial model group at all time points (P<0.01). CONCLUSIONS: The expression of Omi/HtrA2 in kidneys is increased in postasphyxial neonatal rats. The increased Omi/HtrA2 expression may play an important role in the development of postasphyxial renal injury. Treatment with Ucf-101 can reduce the expression of Omi/HtrA2 in kidneys of postasphyxial neonatal rats and thus reduce renal tububar epithelial cell apoptosis.［Chin J Contemp Pediatr, 2010, 12 (8):658-661］
HUA Bing,DONG Wen-Bin,LI Qing-Ping et al. Effects of Ucf-101 on expression of Omi/HtrA2 in kidneys of postasphyxial neonatal rats[J]. CJCP, 2010, 12(08): 658-661.
［2］Wang CY, Lin YS, Su WC, Chen CL, Lin CF. Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis［J］. Mol Biol Cell, 2009, 20(19):4153-4161.
［5］Su D, Su Z, Wang J, Yang S, Ma J. UCF-101, a novel Omi/HtrA2 inhibitor, protects against cerebral ischemia/reperfusion injury in rats［J］. Anat Rec (Hoboken), 2009, 292(6):854-861.
［6］Althaus J, Siegelin MD, Dehghani F, Cilenti L, Zervos AS, Rami A. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion［J］. Neurochem Int, 2007, 50(1):172-180.
［8］Okazaki K, Kondo M, Kato M, Kakinuma R, Nishida A, Noda M, et al．Elevation of cytokine concentrations in asphyxiated neonates ［J］．Biol Neonate， 2006， 89(3)：183-189.
［9］Chang L，Kamata H，Solinas G，Luo JL, Maeda S, Venuprasad K, et al ．The E3 ubiquitin ligase itch couples JNK activation to TNF-α－induced cell death by inducing c-FLIP(L)turnover［J］．Cell， 2006， 124(3)：601-613.
［10］Belizario JE，Alves J，Occhiucci JS，Garay-Malpartida M, Sesso A. A mechanistic view of mitochondrial death decision pores［J］．Braz J Med Biol Res， 2007， 40(8)：1011-l024.
［11］Kin H，Wang NP，Halkos ME, Kerendi F, Guyton RA, Zhao ZQ. Neutrophil depletion reduces myocardial apoptosis and attenuates NF-κB activation /TNF-α release after ischemia and reperfusion ［J］．J Surg Res, 2006, 135（1）：170-178.
［12］Li Q, Hueckstaedt LK, Ren J.UCF101 Ameliorates streptozotocin-induced cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase［J］. Exp Physiol, 2009, 94(9):984-994.
［13］Liu HR, Gao E, Hu A, Tao L, Qu Y, Most P, et al. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion［J］. Circulation, 2005, 111(1):90-96.
［14］Bhuiyan MS, Fukunaga K. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury［J］. Cardiovasc Ther, 2008, 26(3):224-232.
